Articles
Page 4 of 82
-
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O12
-
Erratum to: Disease and patient characteristics in NP-C patients: findings from an international disease registry
Citation: Orphanet Journal of Rare Diseases 2013 8:73 -
Identification of a new variant of TTR involved in familial amyloid cardiomyopathy (FAC) in Brazil: from the patient to the protein
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P55 -
Patient perspective on CT Involvement: are they listening to my needs?
Citation: Orphanet Journal of Rare Disseases 2012 7(Suppl 2):A39 -
Correction to: RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks
An amendment to this paper has been published and can be accessed via the original article.
Citation: Orphanet Journal of Rare Diseases 2021 16:146 -
Social profiles - a dialogue tool
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P14 -
Limb-girdle muscular dystrophy 1F is caused by a microdeletion in the transportin 3 gene
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O20 -
Does the course of Val122Ile differ from SSA, or is selection bias a factor?
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P18 -
Correction to: A Germany-wide survey study on the patient journey of patients with hereditary angioedema
An amendment to this paper has been published and can be accessed via the original article.
Citation: Orphanet Journal of Rare Diseases 2021 16:97 -
Patient experience with hereditary and senile systemic amyloidoses: a survey from the Amyloidosis Research Consortium
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P22 -
A "Family Project" to fight Usher, a rare disease leading to deaf-blindness
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O10 -
Classification and coding of rare diseases: overview of where we stand, rationale, why it matters and what it can change
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A10 -
Correction to: Ketogenic diet for mitochondrial disease: a systematic review on efficacy and safety
Citation: Orphanet Journal of Rare Diseases 2021 16:397 -
Quantitative MR-neurographic parameters can determine and specify nerve injury in amyloid related polyneuropathy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O14 -
Axon reflex-mediated vasodilation is reduced in proportion to disease severity in familial amyloid polyneuropathy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P57 -
Retinal and choroidal vascular abnormalities in TTR-FAP
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P61 -
TTR-FAP: a single-center experience in Sicily, an Italian endemic area
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O1 -
European Porphyria Network (EPNET) for information, epidemiological data, quality and equity of service
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P16 -
DYSCERNE: developing clinical management guidelines for selected dysmorphic syndromes
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P20 -
FHL1 protein isoforms in Emery-Dreifuss muscular dystrophy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O18 -
The nuclear lamina during human spermiogenesis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O22 -
Val50Ala variant of familial amyloid neuropathy – a rare case in the Czech Republic
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P24 -
The Epidermolysis bullosa house in Salzburg
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O12 -
Correction to: Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones
An amendment to this paper has been published and can be accessed via the original article.
Citation: Orphanet Journal of Rare Diseases 2021 16:91 -
Managed entry agreements
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O27 -
Professional clinical guidelines for rare diseases: methodology
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A12 -
Rare diseases and disabilities: improving the information available with three Orphanet projects
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O31 -
DPD Scintigraphy for diagnosis of amyloidosis in 1191 patients– a single centre experience
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O16 -
Perspective having a Centre of Expertise that covers more than one rare disease
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O2 -
Minimal assessment of index cases: the point of view of the neurologist
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I11 -
Cardiomyopathy and peripheral polyneuropathy severity in patients with Glu89Gln mutation at the time of diagnosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P59 -
Specific ophtalmologic changes in late onset familial amyloid polyneuropathy (FAP) portuguese patients
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P63 -
Unravelling the epidemiology of late-onset and asymptomatic carriers of FAP ATTR V30M in a Portuguese population
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O3 -
Evidence-based information guides to rare chromosome disorders for families and professionals
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P18 -
International registry: genetic and phenotypic characteristics of a heterogenous group of disorders
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P22 -
Management of congenital muscular dystrophies related to defects in the LMNA gene
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O24 -
Clinical and laboratory test in patients with familial amyloid polyneuropathy: differences between symptomatic patients and asymptomatic carriers
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P30 -
DYSCERNE: a European Network of Centres of Expertise for Dysmorphology
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O14 -
Correction: Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019
Citation: Orphanet Journal of Rare Diseases 2022 17:260 -
Identifying specific social challenges of rare diseases: current challenges and issues
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O29 -
How reference networks develop, implement, and monitor guidelines
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A14 -
Patient innovation under rare diseases and chronic needs
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O33 -
ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O18 -
Evaluation of Centres: the French experience since 2009
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O4 -
Do we need to demonstrate Amyloid in tissue?
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I13 -
Management of stage 1 TTR FAP: French experience
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P65 -
Correction to: Potential markers for sample size estimations in hereditary spastic paraplegia type 5
Citation: Orphanet Journal of Rare Diseases 2021 16:451 -
Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results
Citation: Orphanet Journal of Rare Diseases 2023 18:55 -
Clinical, epidemiological, genetic, and electrophysiological characteristics of transthyretin familial amyloid polyneuropathies in Israel
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O5 -
Correction to: Growth in ataxia telangiectasia
An amendment to this paper has been published and can be accessed via the original article.
Citation: Orphanet Journal of Rare Diseases 2021 16:248
Follow
- ISSN: 1750-1172 (electronic)